LAWRENCE, Mass., Jan. 28, 2013 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, announced today that NxStage patient advocate Jim Smith, 64, of Indianola, Washington is beginning the first NxStage Home Hemodialysis Patient Awareness Tour of 2013 with a 4-week journey starting January 29th.
The Tour is designed to increase patient awareness of home hemodialysis and consists of Smith, along with his wife and care partner, Claire, making 16 scheduled stops at dialysis centers in Georgia and South Carolina. Smith will speak with dialysis patients about the benefits of more frequent home hemodialysis and perform demonstrations with his NxStage System One ™.
Smith's journey with NxStage began in 2007. Discouraged with how in-center treatment 3 times a week impeded his work, travel, and lifestyle, Smith researched other dialysis options and learned about home therapy with the System One. After completing training with his care partner, he began dialyzing at home with the System One."I understand the challenges of life on dialysis firsthand, and look forward to meeting with other patients to share my experiences with more frequent home hemodialysis with the System One. My goal is to help raise awareness and access to this life-changing therapy," said Smith. "We're really excited to partner with Jim to increase patient awareness of our therapy," said Jeff Burbank, NxStage founder and CEO. "This inspiring tour is a great venue to reach patients and share experiences as well as to demonstrate how therapy with our innovative and portable System One can help transform the quality of life for patients needing dialysis." For more information on Jim's journey with NxStage and the System One, visit, www.nxstage.com/homehemodialysis/patientstories/jim. Smith receives a modest stipend from NxStage as well as reimbursement for travel expenses directly associated with these stops.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV